|
|
|
|
 Dr Chun-Lin Chen,
CEO Shanghai Medicilon Inc., China "Chun-Lin Chen got B.S. and M.S. from China Pharmaceutical University in 1983 and 1986. During 1986-1991, Chun-Lin Chen worked as Assistant Professor in China Pharmaceutical University. In 1994, Dr. Chen got Ph.D. in Pharmacology and Toxicology from Oklahoma State University and then he got postdoctoral training in Pharmaceutical Department of St. Jude Children’s Research Hospital. During 1997-2002, Dr. Chen served as Director of Pharmaceutical Department at Parker Hughes Cancer Center, Parker Hughes Institute, St. Paul, USA. In 2002, Dr. Chen joined Vertex Pharmaceuticals as a Staff Investigator at Department of Pharmacokinetics and Metabolism, Non-clinical Drug Evaluation Division, Vertex Pharmaceuticals Incorporated, Cambridge, USA. He managed pre-clinical drug evaluation team and lead to three IND filing approved by FDA.Appearing: Conference Day Two: Thursday, 18 March 2010 09.45 The Development and Application of in vitro Mitochondria Models in Early Drug Discovery Dr Chun-Lin Chen, CEO,
Shanghai Medicilon Inc., China |
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
|
|
|
|
|
|
